2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow VKA-based Regimen: new trials by email Literature Review of VKA-based Regimen trials Research Report on VKA-based Regimen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) Edoxaban-based Regimen, VKA-based Regimen - Atrial Fibrillation | Phase 3 | Completed | Daiichi Sankyo | 1426 | 2017-03-21 | 2022-03-24 |
| Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation Edoxaban, VKA-Based Regimen - Atrial Fibrillation | Phase 3 | Completed | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 632 | 2017-03-21 | 2019-09-23 |
Daiichi Sankyo (1) · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company (1)
Belgium (2) · Canada (2) · Germany (2) · Italy (2) · Poland (2) · South Korea (2) · Spain (2) · United Kingdom (2) · Austria (1) · Czechia (1) · France (1) · Hungary (1) · Japan (1) · Netherlands (1) · Switzerland (1)
PMID 29663464, PMID 30172099, PMID 33249467, PMID 34274293, PMID 34449183, PMID 40371611, PMID 41263742
2016 (2)